BRCA1 and breast carcinoma: Since PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells to IR (and probably to other DNA damage agents), these could explain, at least in part, why PRMT1 has been identified as a marker of unfavorable prognosis for breast cancer patients38.